vasopressin
pressor agent
hypertensive
process
Vasopressin
pathogenesis
DOCA-salt hypertension
elevation
blood pressure
rats
lithium-treated
diabetes insipidus
DOCA-salt
treatment
Administration
DDAVP
antidiuretic action
vasopressor
increase
blood pressure
levels
administration
AVP
pressor
action
vasopressin
development
model
hypertension
pressor
responsiveness
hormone
initial stage
hypertension
Increased
secretion
vasopressin
neurohypophysis
promotes
function
hormone
pathogenetic factor
hypertension
vasopressin
plasma osmolality
induced
absence
control
angiotensin II forming
receptor binding capacity
sodium balance
brain
vasopressin
human
hypertension
